申请人:Fischer Janos
公开号:US20070093539A1
公开(公告)日:2007-04-26
The invention relates to new N-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates of formula (I).
wherein n represents 0 or 1 mol,
[solvate] represents water, C
1
-C
4
alcohol, C
1
-C
4
alkylester of C
1
-C
3
carboxylic acid or dioxane, and the mixture of solvated (wherein n=1) and solvat-free forms (wherein n=0). Furthermore, the invention relates their process for production and use for the treatment of osteoarthritis and rheumatoid arthritis and surgical and primary dysmenorrheal pains, based on anti-inflammatory and analgesic pharmacological model experiments.
本发明涉及一种新的化合物,即公式(I)中的新N-羟基-4-(3-苯基-5-甲基异噁唑-4-基)-苯磺酰胺溶剂化物。其中n代表0或1摩尔,[溶剂化物]代表水、C1-C4醇、C1-C4羧酸的C1-C3烷基酯或二噁烷,以及溶剂化(其中n = 1)和无溶剂化形式(其中n = 0)的混合物。此外,本发明还涉及其制备方法以及基于抗炎和镇痛药理模型实验用于治疗骨关节炎、类风湿性关节炎和手术性和原发性痛经的用途。